ScreenPoint Medical and Ferrum Health Collaborate to Enhance Breast Cancer Detection with AI

ScreenPoint Medical and Ferrum Health Partner to Offer Transpara Breast AI

Ferrum Health has announced a strategic partnership with ScreenPoint Medical to offer the Transpara Breast AI Suite through its Model Hub. This collaboration aims to enhance breast cancer detection capabilities and streamline radiologists’ workflows.

Introduction to Transpara Breast AI

The Transpara Breast AI Suite includes features such as Detection, Density, and Temporal Comparison, which collectively provide radiologists with a robust tool for identifying cancers earlier. As one of the most clinically validated breast AI solutions globally, Transpara is designed to assist in improving cancer detection rates.

Ferrum Health’s Model Hub

Ferrum Health’s Model Hub serves as a clinical AI governance suite that enables healthcare organizations to transition from fragmented AI deployments to a comprehensive enterprise intelligence program. This platform allows for:

Deployment: A unified foundation for managing and measuring AI across various service lines.
Data Control: Maintaining full control over data security and evidence.
Validation: Facilitating faster and safer integration of proven AI models into clinical workflows.

Benefits of Transpara on Ferrum’s Platform

Peter Eason, COO of Ferrum Health, emphasized that the addition of Transpara Breast AI reflects the current demands of healthcare systems for proven performance and real-world scalability. By integrating Transpara’s capabilities into a governed environment, radiology teams can adopt AI solutions confidently, thereby enhancing early detection and promoting equitable screening outcomes.

Clinical Validation and Impact

The Transpara Breast AI solution is particularly notable for its validation through peer-reviewed research, demonstrating an ability to improve cancer detection rates by up to 29%. This effectiveness persists across variables such as breast density, patient ethnicity, and the experience level of radiologists. It provides a valuable “second pair of eyes” for radiologists, helping to reduce their reading workload for both 2D and 3D mammography.

Future of Care with AI Integration

Albert Gubern-Mérida, Chief Product and Technology Officer at ScreenPoint Medical, remarked on Ferrum Health’s ability to create an integrated AI workflow that aligns with modern healthcare practices. The partnership aims to ensure that healthcare providers have access to the best available algorithms, thus enhancing patient care.

About Ferrum Health

Ferrum Health specializes in connecting AI insights across service lines, transforming fragmented deployments into cohesive enterprise clinical intelligence. Their vendor-neutral suite is designed to validate and monitor clinical AI models securely within a health system’s environment. With backing from $31 million in funding, Ferrum serves over 350 care sites globally.

About ScreenPoint Medical

ScreenPoint Medical focuses on leveraging AI technology to improve breast imaging. Their commitment is to enhance the consistency and accuracy of breast cancer detection, thereby translating opportunities into tangible health outcomes for patients. Transpara Breast AI is recognized and trusted by radiologists worldwide.